New therapies in chronic prostatitis

ArticleinCurrent Urology Reports 8(4):313-8 · July 2007with14 Reads
Impact Factor: 1.51 · DOI: 10.1007/s11934-007-0078-5 · Source: PubMed

    Abstract

    The optimal management of category III prostatitis (chronic pelvic pain syndrome) is not known. Conventional therapy usually consists of prolonged courses of antibiotics; however, clinical trials have never shown their efficacy. Newer therapies with some evidence for efficacy include alpha-blockers, anti-inflammatory phytotherapy (quercetin, bee pollen), physiotherapy, neuroleptics, and others with unique actions such as antinanobacterial treatment. A stepwise approach involving multiple treatment modalities is often successful for patients with this common and frustrating condition.